Editorial: tofacitinib and biologics for moderate‐to‐severe ulcerative colitis—what is best in class? Authors’ reply

Linked Content This article is linked to Bonovas et al and Tsai papers. To view these articles visit https://doi.org/10.1111/apt.14449 and https://doi.org/10.1111/apt.14480.

Saved in:
Bibliographic Details
Published in:Alimentary pharmacology & therapeutics Vol. 47; no. 4; pp. 540 - 541
Main Authors: Bonovas, S., Lytras, T., Nikolopoulos, G., Peyrin‐Biroulet, L., Danese, S.
Format: Journal Article
Language:English
Published: England Wiley Subscription Services, Inc 01-02-2018
Subjects:
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Linked Content This article is linked to Bonovas et al and Tsai papers. To view these articles visit https://doi.org/10.1111/apt.14449 and https://doi.org/10.1111/apt.14480.
Bibliography:SourceType-Other Sources-1
content type line 63
ObjectType-Editorial-2
ObjectType-Commentary-1
ISSN:0269-2813
1365-2036
DOI:10.1111/apt.14486